Stephen F. Betz Crinetics Pharmaceuticals, Inc. (CRNX) insider trading activity
Stephen F. Betz is Chief Scientific Officer of Crinetics Pharmaceuticals, Inc.. Currently has a direct ownership of 99,713 shares of CRNX, which is worth approximately $3.41 Million. The most recent transaction as insider was on Dec 15, 2021, when has been sold 5,668 shares (Common Stock) at a price of $24.14 per share, resulting in proceeds of $136,826. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
99.7K
0%
3M change
45.41%
12M change
Total Value Held
$3.41 Million
Stephen F. Betz Transaction History
SFB
Stephen F. Betz
Chief Scientific Officer
San Diego, CA